Selective miscarriage of Down's syndrome fetuses in women aged 35 years and older

No abstract is available for this paper.

• Publication year

  1995

• Venue

  British Journal of Obstetrics and Gynaecology

• Publication date

  1995-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1471-0528.1995.tb10845.xPMID 7547736
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The frequency of 47,+21, 47,+18, and 47,+13 at the uppermost extremes of maternal ages: results on 56,094 fetuses studied prenatally and comparisons with data on livebirths

  2004cited by this paper
• First trimester biochemical screening for Down's syndrome.

  1994cited by this paper
• Maternal age‐specific risks for trisomies at 9—14 weeks' gestation

  1994cited by this paper
• Biochemical screening for Down’s syndrome in the first trimester of pregnancy

  1993cited by this paper
• Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.

  1992cited by this paper
• Cytogenetic evidence for enhanced selective miscarriage of trisomy 21 pregnancies with advancing maternal age.

  1992cited by this paper
• Cytogenetic findings in 1250 chorionic villus samples obtained in the first trimester with clinical follow‐up of the first 1000 pregnancies

  1989cited by this paper
• Screening for Down's syndrome.

  1988cited by this paper
• Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alphafetoprotein level

  1988cited by this paper
• Maternal age-specific rates of 47,+21 and other cytogenetic abnormalities diagnosed in the first trimester of pregnancy in chorionic villus biopsy specimens: comparison with rates expected from observations at amniocentesis.

  1988cited by this paper
• Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein level

  1987cited by this paper
• Maternal age specific rates for chromosome aberrations and factors influencing them: Report of a collaborative european study on 52 965 amniocenteses

  1984cited by this paper
• Chromosome abnormalities and spontaneous fetal death following amniocentesis: further data and associations with maternal age.

  1983cited by this paper

• Screening and Predictive Biomarkers for Down Syndrome Through Amniotic Fluid Metabolomics

  2024cites this paper
• Pathobiochemistry of inhibin A and its use in the screening of congenital developmental defects

  2020cites this paper
• Maternal age in the epidemiology of common autosomal trisomies

  2020cites this paper
• Intrauterine death in singleton pregnancies with trisomy 21, 18, 13 and monosomy X.

  2016cites this paper
• Down syndrome: perinatal mortality risks with each additional week of expectant management

  2016cites this paper
• Prenatal Diagnosis of Chromosomal Abnormalities through Chorionic Villus Sampling and Amniocentesis

  2015cites this paper
• Óbito fetal em gestações únicas com diagnóstico de trissomias dos cromossomos 21, 18, 13 e monossomia do X

  2014cites this paper
• UvA-DARE ( Digital Academic Repository ) On first trimester Down syndrome screening

  2012cites this paper
• Innovations in Down Syndrome Screening

  2011cites this paper
• Prenatal Diagnosis of Chromosomal Abnormalities through Amniocentesis

  2010cites this paper
• Down syndrome screening: imagining the screening test of the future

  2010cites this paper
• Genealogic Study in Down Syndrome

  2007cites this paper
• Maternal age‐specific fetal loss rates in Down syndrome pregnancies

  2006cites this paper
• Down syndrome and precocious menopause

  2005cites this paper
• Raskauden ajan ultraäänitutkimukset ja seerumiseulonnat rakenne- ja kromosomipoikkeavuuksien tunnistamisessa

  2005cites this paper
• The level of ADAM12‐S in maternal serum is an early first‐trimester marker of fetal trisomy 18

  2005cites this paper
• An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.

  2004cites this paper
• Screening for Down's syndrome in early and late first and second trimester using six maternal serum markers

  2003cites this paper
• Maternal Serum Screening in Ontario Using the Triple Marker Test

  2003cites this paper
• FIRST TRIMESTER SCREENING FOR DOWN SYNDROME

  2003cites this paper
• Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies.

  2001cites this paper
• Nuchal translucency measurement and pregnancy outcome after assisted conception versus spontaneously conceived twins.

  2001cites this paper
• Down syndrome in the Czech Republic during 1961-1997: prevalence, prenatal diagnosis and maternal-age-specific rates

  2001cites this paper
• Nuchal Translucency and the Acceptance of Invasive Prenatal Chromosomal Diagnosis in Women Aged 35 and Older

  2001cites this paper
• What is the true fetal loss rate in pregnancies affected by trisomy 21 and how does this influence whether first trimester detection rates are superior to those in the second trimester?

  2001cites this paper
• Evaluation of strategies for Downs Syndrome screening

  2000cites this paper
• Fetal hepatic haemangioendothelioma: a new association with elevated maternal serum alpha‐fetoprotein

  2000cites this paper
• Survival of Down syndrome in utero

  2000cites this paper
• FISH in prenatal diagnosis

  2000cites this paper
• Down syndrome fetal loss rate in early pregnancy

  2000cites this paper
• Improving the position of women in medicine

  1999cites this paper
• Improving pregnancy outcome in twin gestations with one malformed fetus by postponing selective feticide in the third trimester.

  1999cites this paper
• Effect of study design on the association between nuchal translucency measurement and Down syndrome.

  1999cites this paper
• Pregnancy outcome and nuchal translucency measurements in fetuses with a normal karyotype

  1999cites this paper
• Use of the disutility ratio in prenatal screening for Down's syndrome

  1999cites this paper
• Current french practices for prenatal diagnosis of trisomy 21: a population‐based study in Paris, 1992–97

  1999cites this paper
• Down's syndrome, cardiac anomalies, and nuchal translucency

  1999cites this paper
• Ultrasonographic screening for fetal chromosomal abnormalities in early pregnancy

  1999cites this paper
• Elective cytogenetic amniocentesis in the third trimester for pregnancies with high risk factors.

  1999cites this paper
• Fetal loss in Down syndrome pregnancies

  1999cites this paper
• Fetal loss in Down syndrome pregnancies

  1999cites this paper
• The proform of eosinophil major basic protein: a new maternal serum marker for Down syndrome

  1999cites this paper
• Elective cytogenetic amniocentesis in the third trimester for pregnancies with high risk factors

  1999cites this paper
• Letter. Correct estimation of parameters for ultrasound nuchal translucency screening

  1998cites this paper
• Schwangerschafts protein 1 (SP1) adds little to the age‐related detection of fetal Down syndrome in the first trimester of pregnancy

  1998cites this paper
• Estimating the spontaneous loss of Down syndrome fetuses between the times of chorionic villus sampling, amniocentesis and livebirth

  1998cites this paper
• Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery.

  1998cites this paper
• Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery

  1998cites this paper
• Prenatal screening

  1998cites this paper
• Screening for Down's Syndrome: The Effect of Test Date on the Detection Rate

  1998cites this paper
• Anomalies in Down syndrome individuals in a large population-based registry.

  1998cites this paper
• Screening for Down's syndrome by fetal nuchal translucency measurement in a high‐risk population

  1998cites this paper
• Variation in biochemical screening for Down's syndrome in the United Kingdom

  1998cites this paper
• Screening of maternal serum for fetal Down's syndrome in the first trimester.

  1998cites this paper
• Increased nuchal translucency and fetal chromosomal defects.

  1998cites this paper
• Age-specific incidences of chromosome abnormalities at the second trimester amniocentesis for Japanese mothers aged 35 and older: collaborative study of 5484 cases

  1998cites this paper
• Increased nuchal translucency and fetal chromosomal defects.

  1998cites this paper
• Antenatal Screening for Down's Syndrome

  1997cites this paper
• Women's opinions and the implications of first‐ versus second‐trimester screening for fetal Down's syndrome

  1997cites this paper
• Prenatal Diagnosis in Denmark

  1997cites this paper
• Elective late fetal karyotyping

  1996cites this paper
• The diagnostic value of the triple test in the diagnosis of Down's syndrome.

  1996cites this paper
• Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation.

  1996cites this paper
• Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy

  1996cites this paper
• The selective miscarriage of Down's syndrome from 10 weeks of pregnancy

  1996cites this paper
• Screening of fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation

  1996cites this paper
• Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks to gestation

  1996cites this paper
• Down's syndrome screening with nuchal translucency.

  1996cites this paper
• First trimester serum screening for down's syndrome

  1995cites this paper
• Genetic library

  1993cites this paper